DUBLIN--(BUSINESS WIRE)--The "Heparin Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report has been added to ResearchAndMarkets.com's offering.
The report on global heparin market provides qualitative and quantitative analysis for the period of 2015 to 2023. The report predicts the global heparin market to grow at a CAGR of 6.7% over the forecast period of 2017-2023. The study on the heparin market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2015 to 2023.
How this report delivers?
- Comprehensive analysis of global as well as regional markets of the heparin market.
- Complete coverage of all the segments in Heparin Market to analyze the trends, developments in the global market and forecast of market size up to 2023.
- Comprehensive analysis of the companies operating in the global Heparin Market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Global Heparin Market by Type of Product
- Low Molecular Weight Heparin
- Unfractionated Heparin
- Ultra-low Molecular Weight Heparin
Global Heparin Market by Route of Administration
- IV Injection
- Subcutaneous Injection
Global Heparin Market by Route of Application
- Clinical Trials
- Medical Devices
- Venous Thromboembolism
Global Heparin Market by End Users
- Blood and Stem Cell Bank
- Sanofi SA
- GlaxoSmithKline plc
- Leo Pharma
- Dr. Reddy's Laboratories
- Fresenius SE & Co. KG
- Teva Pharmaceutical Industries Ltd.
- Baxter International
- Aspen Holdings
Key Topics Covered:
2. Executive Summary
3. Global Heparin Market Overview
4. Global Heparin Market by Type of Product
5. Global Heparin Market by Route of Administration
6. Global Heparin Market by Applications
7. Global Heparin Market by End Users
8. Global Heparin Market by Region 2017-2023
9. Company Covered
For more information about this report visit https://www.researchandmarkets.com/research/x567k2/global_heparin?w=4